Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 2,406 shares at $40.50 ($97K) on 2025-01-21, disclosed to the SEC on 2025-01-22.
Scheduled sale ($97k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |